Welcome to the
Hepatitis B Foundation
OnCore Biopharma Licenses 2nd Generation Cyclophilin Inhibitors From NeuroVive for the Treatment of Chronic HBV Infection
Sept 15 – Located in the PA Biotech Center in Doylestown, OnCore secures exclusive rights to NVP018, which will complement their existing pipeline directed at achieving an all-oral cure for hepatitis B. Read more.
Recommendations to Improve Liver Health in Hepatitis B, Hepatitis C Patients
Sept 15 - Although it is widely understood that hepatitis B and hepatitis C are the leading causes of liver cirrhosis and liver cancer, a study published in Cancer Nursing reports an alarming number of HBV and HCV carriers have unhealthy habits that result in poor liver health. Read more.
Increase Seen in Liver Injury Caused by Herbals, Dietary Supplements
Sept 15 – New research shows that liver injury caused by herbals and dietary supplements increased from 7% to 20% in a U.S. study group over a ten-year period. Read more.
SAARC Experts Join Hands to Combat Liver Diseases
Sept 15 – With rising incidences of liver diseases in South Asian countries, experts from SAARC nations have come together to chalk out strategies to combat these diseases in the region and will include effective guidelines for the prevention and treatment. Read more.
Hep B United Issues Recommendations on HHS Action Plan
Aug 18 – Hep B United released a blueprint report highlighting recommendations on how local coalitions and federal agencies can collaborate to further the goals identified in the U.S. Department of Health and Human Services?(HHS) Action Plan for the Prevention, Care, & Treatment of Viral Hepatitis. Read more.
Hepatitis B Foundationís Joan Block Honored at White House
Aug 4 – In commemoration of World Hepatitis Day, the White House recognized and honored leadership efforts to combat viral hepatitis. HBF is proud to announce co–founder and executive director, Joan Block, a recipient of this prestigious award! Read more.
Journal for American Association of Physician Assistants (JAAPA) Publishes HBF Clinical Algorithm
June 5 - This article represents the last major primary care journal that has published the Hepatitis B Foundation’s clinical algorithm for the screening, evaluation and monitoring of hepatitis B in the primary care setting. The other journals include J. of Family Practice, American J. Medicine, The Female Patient, and J. of Nurse Practitioners. Read more.
Page last modified September 15, 2014